Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease

Published:2020-12-05 Issue:6 Volume:76 Page:1861-1864
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Higham Andrew¹^ORCID,Beech Augusta¹²,Wolosianka Sophie²,Jackson Natalie²,Long Gabriella¹,Kolsum Umme¹,Southworth Thomas²^ORCID,Pham Tuyet‐Hang³,Sridhar Sriram⁴,McCrae Christopher³,Newbold Paul⁵,Singh Dave¹²

Affiliation:

1. Division of Infection, Immunity and Respiratory Medicine School of Biological Sciences Faculty of Biology, Medicine and Health Manchester Academic Health Science Centre The University of ManchesterManchester University NHS Foundations Trust Manchester UK

2. Medicines Evaluation Unit Manchester UK

3. Translational Science & Experimental Medicine Early Respiratory & Immunology, Research and Early Development AstraZeneca Gaithersburg MD USA

4. Translational Science Oncology R&D AstraZeneca Gaithersburg MD USA

5. Biopharmaceuticals Medical AstraZeneca Gaithersburg MD USA

Funder

Manchester Biomedical Research Centre

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.14661